Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacokinetics
5 evidence topics · 4 sources
Plasma pharmacokinetic parameters after intrathecal administration
| Parameter, mean (CV%) | 200 mg | 300 mg | 600 mg | 900 mg |
|---|---|---|---|---|
| AUC0-last (hr·mcg/mL) | “39 (19%)” | “51 (14%)” | “101 (34%)” | “167 (40%)” |
| Cmax (mcg/mL) | “2.4 (33.7%)” | “4.5 (77.3%)” | “6.3 (37%)” | “8.4 (84.3%)” |
Absorption, distribution, and elimination
Cerebrospinal fluid and plasma pharmacokinetics after intracerebroventricular dosing in the NIH phase 1 trial
“Three NPC1 subjects were admitted to the NIH Clinical Center Intensive Care Unit and an Ommaya reservoir was surgically placed on the nondominant side.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Following the ICV injection of 50 mg HP-β-CD, high CSF concentrations of HP-β-CD were observed with the Cmax ranging from approximately 520 to 1,500 μg/ml in three patients (Table 4).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The mean Vdss of ∼130 ml was approximately to the reported CSF volume in humans.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The estimated mean t1/2 for HP-β-CD in CSF was 6.58 h based on the RP-UPLC-MS/MS method and 10.1 h based on the 2D-LC-IF-MS/MS method.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The mean Cmax and AUC of HP-β-CD in plasma were less than 0.3% of the corresponding CSF PK parameters.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The estimated mean t1/2 values for HP-β-CD in plasma were 12.4 h based on the RP-UPLC-MS/MS method and 15.1 h based on the 2D-LC-IF-MS/MS method.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Central nervous system distribution after a single intrathecal dose in cats
“In this study, tissue distribution was investigated in normal cats that received a single 120‐mg dose of [14C]‐HP‐β‐CD (approximately 200 μCi/cat) via the cerebellomedullary cistern (CBMC) and lumbar cistern.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HP‐β‐CD‐derived radioactivity penetrated into the deeper parts of the central nervous system with the highest concentration at 4 hours (403 μg Eq/g or 0.28 mM) and remained high (49.7 μg Eq/g or 0.03 mM) at 24 hours.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The relatively long half‐life (11‐30 hours) in cerebral ventricles and the subarachnoid space surrounding the brain and spinal cord might contribute to the efficacy of HP‐β‐CD in NPC1 cats.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote